Patent details

Basic Information

Publication number:

LUC00292

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP177583887

Legal Status:

Pending & Published

Application number:

LUC00292

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/22/1671

Marketing Authorization Type:

Marketing Authorization Date:

19/08/2022

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

13/12/2022

First Marketing Authorization date:

19/08/2022

Grant date:

Activation date:

Publication date:

14/12/2022

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

19/08/2037

SPC Extension Expiration:

19/08/2037

Rejection date:

Withdrawal date:

Owner

From:

13/12/2022

 

 

Name:

Gilead Sciences, Inc.

Address:

333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:

Dennemeyer & Associates S.A.

From:

13/12/2022

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2023/01

Publication date:

03/01/2023

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Filing date	Document type	Number of pages
13/12/2022	Application Form	5
13/12/2022	General Document	2
13/12/2022	Summary of the product caracteristics	63
13/12/2022	Marketing authorization	3
13/12/2022	Marketing authorization	2
13/12/2022	MA publication	8
14/12/2022	Outgoing Correspondence	1
14/12/2022	Publication	1